{"id":273048,"date":"2026-09-28T09:57:33","date_gmt":"2026-09-28T04:27:33","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=273048"},"modified":"2026-09-28T09:57:33","modified_gmt":"2026-09-28T04:27:33","slug":"why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/","title":{"rendered":"Bliss GVS Pharma Stock Scales New 52-Week Peak at Rs 745: Key Reasons Behind the Surge"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\">Bliss GVS Pharma Ltd. (BLISSGVS-BE)<\/a> share price reached a fresh 52-week high of Rs 744.75 today and later stood at Rs 742, up 4.61% from the previous close. Market cap was Rs 7,542.02 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 28 September 2026 at 9:52 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Bliss GVS Pharma Share Price moved to Rs 742 on 28 September 2026, up Rs 32.70 or 4.61% from the previous close of Rs 709.30, after touching a fresh 52-week high of Rs 744.75. The company\u2019s market capitalisation stood at Rs 7,542.02 Cr, placing the move in the context of a sizeable listed healthcare name. For readers tracking Bliss GVS Pharma Share Price Today on Univest, the key facts are straightforward: the stock printed a new yearly high, finished close to that level, and did so without any company-specific catalyst being established in the supplied data.<\/p>\n<p>The latest snapshot also shows the day opened at Rs 705 and stayed within a relatively tight intraday range versus the fresh high. Turnover stood at Rs 12.9 Cr. The move is therefore important for Bliss GVS Pharma Share News because it confirms the price event itself, while the supplied information does not identify a separate trigger. In this Bliss GVS Pharma Stock News update, the focus is on what is verified: a fresh 52-week high, a higher closing price than the previous session, and a valuation profile that deserves a closer fundamental reading on Univest.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#Bliss_GVS_Pharma_Share_Price_Today_Price_Action_Analysis\" title=\"Bliss GVS Pharma Share Price Today: Price Action Analysis\">Bliss GVS Pharma Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#Bliss_GVS_Pharma_Ltd_BLISSGVS-BE_Fundamental_Analysis\" title=\"Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis\">Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#Why_Investors_Are_Watching_Bliss_GVS_Pharma\" title=\"Why Investors Are Watching Bliss GVS Pharma\">Why Investors Are Watching Bliss GVS Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#About_Bliss_GVS_Pharma\" title=\"About Bliss GVS Pharma\">About Bliss GVS Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#Track_Bliss_GVS_Pharma_Share_Price_on_Univest\" title=\"Track Bliss GVS Pharma Share Price on Univest\">Track Bliss GVS Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#Why_did_Bliss_GVS_Pharma_Share_Price_move_today\" title=\"Why did Bliss GVS Pharma Share Price move today?\">Why did Bliss GVS Pharma Share Price move today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#What_is_Bliss_GVS_Pharma_Share_Price_today\" title=\"What is Bliss GVS Pharma Share Price today?\">What is Bliss GVS Pharma Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#What_is_the_fresh_52-week_high_for_Bliss_GVS_Pharma\" title=\"What is the fresh 52-week high for Bliss GVS Pharma?\">What is the fresh 52-week high for Bliss GVS Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#How_is_Bliss_GVS_Pharma_valued\" title=\"How is Bliss GVS Pharma valued?\">How is Bliss GVS Pharma valued?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#What_do_Bliss_GVS_Pharma_earnings_and_book_value_show\" title=\"What do Bliss GVS Pharma earnings and book value show?\">What do Bliss GVS Pharma earnings and book value show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-ltd-share-price-52-week-high-2026-09-28\/#How_does_Bliss_GVS_Pharma_compare_with_its_industry_peers\" title=\"How does Bliss GVS Pharma compare with its industry peers?\">How does Bliss GVS Pharma compare with its industry peers?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Bliss GVS Pharma Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 742<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 709.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 32.7 (+4.61%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 705<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 744.75<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 705<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 12.9 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,542.02 crore<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) traded at Rs 742 versus the previous close of Rs 709.3, a rise of 4.61%. The stock opened at Rs 705, reached a high of Rs 744.75 and touched a low of Rs 705.<\/p>\n<p>Bliss GVS Pharma Share Price Today reflected a clear upward session, with the stock opening at Rs 705, matching the day low, and reaching Rs 744.75, which was also the fresh 52-week high. The latest price was Rs 742, leaving the stock Rs 32.70 above the previous close of Rs 709.30. That is a day gain of 4.61%, which makes the session relevant for anyone following Bliss GVS Pharma Share Price Live or checking Bliss GVS Pharma Share Price Update on market news feeds.<\/p>\n<p>The day\u2019s range stayed between Rs 705 and Rs 744.75, so the stock ended near the upper end of the session. Turnover of Rs 12.9 Cr gives a factual measure of traded value for the day, but it should be read only as a transaction value and not as a proxy for any hidden market behaviour. For Bharat investors searching Bliss GVS Pharma Share Price Today or Bliss GVS Pharma Latest News, the core event is simple: the stock set a fresh one-year high and closed just below that level.<\/p>\n<p>Because the fresh 52-week high is a price event rather than a company announcement, the next useful step is to examine valuation and business performance together with the sector context. That is the right bridge from price action into the broader Bliss GVS Pharma Share Price story on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bliss_GVS_Pharma_Ltd_BLISSGVS-BE_Fundamental_Analysis\"><\/span><strong>Bliss GVS Pharma Ltd. (BLISSGVS-BE) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,542.02 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">55.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.12x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.11%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 12.81<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 115.94<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.21%<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) fundamental metrics show P\/E 55.38x, P\/B 6.12x, ROE 12.11%, ROCE 17.4%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Bliss GVS Pharma Ltd. has a market capitalisation of Rs 7542.02 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 55.38x, P\/B at 6.12x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.11% and ROCE of 17.4%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 12.81, book value per share of Rs 115.94, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.67x, median ROE of 11.43%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">55.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.59x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.46x to 735.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.12x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.11%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">17.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7,542.02 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 722.23 crore<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P\/E ratio of 55.38x, which is above the benchmark median of 32.67x, a difference of +69.51%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROE of 12.11%, which is above the benchmark median of 11.43%, a difference of +5.95%. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a ROCE of 17.4%, which is above the benchmark median of 13.1%, a difference of +32.82%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/innovacap\/innova-captab-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Innova Captab Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INNOVACAP<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,335.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sanofi\/sanofi-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sanofi India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SANOFI<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,231.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55.46<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/supriya\/supriya-lifescience-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Supriya Lifescience Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUPRIYA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,926.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aartipharm\/aarti-pharmalabs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aarti Pharmalabs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AARTIPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8,514.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/morepenlab\/morepen-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Morepen Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MOREPENLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6,600.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.19<\/td>\n<\/tr>\n<\/table>\n<p>Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a P\/E ratio of 55.38x compared with the displayed peer median of 39.96x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.11% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 17.4% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS-BE) has a market capitalisation of Rs 7,542.02 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Bliss_GVS_Pharma\"><\/span><strong>Why Investors Are Watching Bliss GVS Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The stock touched a fresh 52-week high of Rs 744.75 and last traded at Rs 742.<\/li>\n<li>The day\u2019s gain was Rs 32.70, or 4.61%, versus the previous close of Rs 709.30.<\/li>\n<li>Market capitalisation stood at Rs 7,542.02 Cr in the latest snapshot.<\/li>\n<li>The company reported P\/E of 55.38, P\/B of 6.12, ROE of 12.11% and ROCE of 17.4%.<\/li>\n<li>Revenue and net profit for Jun 2026 were Rs 2,855.76 Cr and Rs 500.97 Cr, respectively.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Bliss_GVS_Pharma\"><\/span><strong>About Bliss GVS Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bliss GVS Pharma Ltd. is classified in Healthcare and the Pharmaceuticals &amp; Drugs industry. That classification is the core business context supplied for the stock, and it is the correct frame for reading its share price, valuation and peer comparisons. For Bliss GVS Pharma Share Price followers on Univest, the relevant company overview here is the industry position and sector classification that the market uses to compare it with other listed pharmaceuticals and drugs names.<\/p>\n<p>The company\u2019s latest financial and market data should therefore be viewed through the same healthcare lens. When readers search Bliss GVS Pharma Share Price or Bliss GVS Pharma Share Price Today, they are usually looking for a factual update, and the supplied dataset provides exactly that: price action, sector membership, valuation, earnings and capital efficiency.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Bliss_GVS_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Bliss GVS Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\">Bliss GVS Pharma Ltd. (BLISSGVS-BE) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Readers can track Bliss GVS Pharma Share Price on Univest for live price updates, financial ratios, shareholding pattern, sector context, peer comparisons and the latest 52-week levels. Univest presents the stock in a format that helps users review Bliss GVS Pharma Stock News, Bliss GVS Pharma Latest News and Bliss GVS Pharma Stock Analysis in one place.<\/p>\n<p>It also helps users revisit Bliss GVS Pharma Fundamental Analysis alongside company-specific market information without mixing in unsupported claims. For market followers who want a clean factual view of Bliss GVS Pharma Share Price Today, Univest keeps the data and the context together.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Bliss_GVS_Pharma_Share_Price_move_today\"><\/span><strong>Why did Bliss GVS Pharma Share Price move today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Share Price rose 4.61% to Rs 742 and touched Rs 744.75, a fresh 52-week high. The supplied data confirms the price event, but it does not establish a company-specific catalyst.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Bliss_GVS_Pharma_Share_Price_today\"><\/span><strong>What is Bliss GVS Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma Share Price today stood at Rs 742 in the latest snapshot. The stock opened at Rs 705, touched Rs 744.75 and closed near the day\u2019s upper end.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_fresh_52-week_high_for_Bliss_GVS_Pharma\"><\/span><strong>What is the fresh 52-week high for Bliss GVS Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The fresh 52-week high for Bliss GVS Pharma was Rs 744.75. That level also matched the day\u2019s high, while the latest quoted price was slightly below it at Rs 742.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Bliss_GVS_Pharma_valued\"><\/span><strong>How is Bliss GVS Pharma valued?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma has a P\/E of 55.38 and a P\/B of 6.12. Both are above the same-industry median benchmarks, which places the valuation above the industry median on these measures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Bliss_GVS_Pharma_earnings_and_book_value_show\"><\/span><strong>What do Bliss GVS Pharma earnings and book value show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> EPS is 12.81 and book value is Rs 115.94. These numbers show earnings attributable to each share and the accounting net worth behind each share, helping frame the share price context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Bliss_GVS_Pharma_compare_with_its_industry_peers\"><\/span><strong>How does Bliss GVS Pharma compare with its industry peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bliss GVS Pharma\u2019s P\/E of 55.38 is above several supplied peers and below Symbiotec Pharmalab. Its ROCE of 17.4% is above Innova Captab, Aarti Pharmalabs and Morepen Laboratories in the peer set.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bliss GVS Pharma Ltd. Share Price hits a new 52-week high at Rs 742. marking a 4.61% rise today. Market cap stands at Rs 7,542.02 crore.<\/p>\n","protected":false},"author":29,"featured_media":273047,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-273048","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["273047"],"rank_math_title":["Bliss GVS Pharma Share Price: price action and valuation"],"rank_math_description":["Bliss GVS Pharma Share Price hit a fresh 52-week high at Rs 744.75. Read the latest price action, valuation, fundamentals and sector view."],"rank_math_focus_keyword":["Bliss GVS Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/bliss-gvs-pharma-stock-scales-new-52-week-peak-at-rs-745-key-reasons-behind-the.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=273048"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273048\/revisions"}],"predecessor-version":[{"id":273049,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273048\/revisions\/273049"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/273047"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=273048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=273048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=273048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}